OZTURK, Z. Et Al. 2015. Thalassemia major patients using iron chelators showed a reduced plasma thioredoxin level and reduced thioredoxin reductase activity, despite elevated oxidative stress. FREE RADICAL RESEARCH , vol.49, no.3 , 309-316.

OZTURK, Z., GENC, G. E., Kupesiz, A., KURTOGLU, E., & GÜMÜŞLÜ, S., (2015). Thalassemia major patients using iron chelators showed a reduced plasma thioredoxin level and reduced thioredoxin reductase activity, despite elevated oxidative stress. FREE RADICAL RESEARCH , vol.49, no.3, 309-316.

OZTURK, Z. Et Al. "Thalassemia major patients using iron chelators showed a reduced plasma thioredoxin level and reduced thioredoxin reductase activity, despite elevated oxidative stress," FREE RADICAL RESEARCH , vol.49, no.3, 309-316, 2015

OZTURK, Z. Et Al. "Thalassemia major patients using iron chelators showed a reduced plasma thioredoxin level and reduced thioredoxin reductase activity, despite elevated oxidative stress." FREE RADICAL RESEARCH , vol.49, no.3, pp.309-316, 2015

OZTURK, Z. Et Al. (2015) . "Thalassemia major patients using iron chelators showed a reduced plasma thioredoxin level and reduced thioredoxin reductase activity, despite elevated oxidative stress." FREE RADICAL RESEARCH , vol.49, no.3, pp.309-316.

@article{article, author={Z. OZTURK Et Al. }, title={Thalassemia major patients using iron chelators showed a reduced plasma thioredoxin level and reduced thioredoxin reductase activity, despite elevated oxidative stress}, journal={FREE RADICAL RESEARCH}, year=2015, pages={309-316} }